TROYA Therapeutics

Private

CopenhagenHealthcare & Life Scienceshttps://troya-tx.com/

Last Round

Accelerator

Jan 15, 2026

Total Funding Raised

$2.77M

Company Overview

TROYA Therapeutics is a biotechnology company that develops engineered protein-based therapeutics designed to improve drug control for safety and efficacy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biotherapeutics platformprotein engineeringprodrug technologyimmuno-oncologytargeted cancer therapyconditionally active biologicsdrug discovery platformdisease-site activationoff-target toxicity reductionnovel protein scaffoldbiotech partnershipsuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TROYA Therapeutics Comparables

Compare TROYA Therapeutics with similar companies based on industry and business-model similarity.

TROYA Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Bonum Therapeutics	84%
Revitope Oncology, Inc.	80%
CytomX Therapeutics	78%

View all Comparables

TROYA Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Jan 15, 2026
Accelerator	Aug 29, 2024
Grant	Dec 14, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Austin Boesch

CEO

Executive Team

TROYA Therapeutics Investors

Notable investors and investment history

TROYA Therapeutics investors
Investor	Rounds
Novo Nordisk Foundation	Grant
BioInnovation Institute	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 29, 2024
$550K round led by BioInnovation Institute

View all signals

TROYA Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TROYA Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TROYA Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen

Employee Range9

Year Founded2023

Last FundingJan 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.